January22nd,2021By Lori LeskoOut with the old, in with the newNew cancer immunotherapy shows promise in treating cancer
January22nd,2021By Ilene SchneiderHCA with 3D modelsInSphero-Yokogawa partnership will support drug development research
January22nd,2021By Mel J. YeatesTalking about a resolutionData show that OSE-230 can resolve chronic inflammation
January22nd,2021By Mel J. YeatesIntroducing NGM438NGM438 is an antagonist antibody that inhibits LAIR1
Respiratory DiseaseJanuary21st,2021By DDN StaffBreathing easier with statins?InVixa, UC Davis team up to develop inhaled statins for the treatment of COVID-19
Cancer ResearchJanuary11th,2021By DDN StaffLearning new techniques against lymphomasResearchers have published on a new CAR-T cell therapy using CXCR5
Cancer ResearchJanuary4th,2021By Lori LeskoExosomes to the rescue in cancerCodiak demonstrates potential of engineered exosomes to stimulate targeted, antitumor immunity
Infectious Disease & VaccinesJanuary4th,2021By Mel J. YeatesGood news for PolyPEPI-SCoV-2PepTC reports positive preclinical results for peptide vaccine
January4th,2021By Lori LeskoPassage makes progress against rare lysosomal storage diseasePreclinical data show injection of optimized AAV vector may correct gangliosidosis
Tools & Techniques NewsJanuary4th,2021By Ilene SchneiderDeep learning for drug designMetabolite Translator assesses safety of novel compounds